| http://www.w3.org/ns/prov#value | - The actual dosage of a DNA oligonucleotide formulation will depend on a number of factors, including the health of the individual patient and the progressive of ALS. Generally, 0.001 ug to loug will be administered in a pharmaceutically acceptable formulation as described herein.
|
